CellGenix is a leading global supplier of high-quality ancillary products, reagents and tools for cell and gene therapy and regenerative medicine applications. As the first company to obtain a GMP manufacturing authorization for cell processing in Europe, we offer 25 years of expertise in GMP manufacturing and development of cell therapy products. Our products are used worldwide in clinical trials by academia and industry partners.
To ensure a seamless transition from research to commercialization we offer a comprehensive product portfolio together with expert regulatory and technical support. Our products combine a maximum of quality and safety due to the state-of-the-art production, stringent in-house quality control and comprehensive documentation.
CellGenix operates a state-of-the-art GMP facility for production of recombinant proteins and cell processing in Freiburg, Germany. A subsidiary is located near Boston in Portsmouth, NH/USA.